Provided by Tiger Trade Technology Pte. Ltd.

Iterum Therapeutics Plc

0.0300
0.0000
Volume:- -
Turnover:- -
Market Cap:1.60M
PE:-0.04
High:0.0300
Open:0.0300
Low:0.0300
Close:0.0300
52wk High:1.42
52wk Low:0.0271
Shares:53.29M
Float Shares:52.38M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7366
EPS(LYR):-1.2576
ROE:-555.68%
ROA:-53.28%
PB:-0.22
PE(LYR):-0.02

Loading ...

Company Profile

Company Name:
Iterum Therapeutics Plc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.